ARVO 2021 Accredited Continuing Education

Print

ARVO 2021 Accredited Continuing Education 

Launch date: July 22
Expiration date: Dec. 31

The Continuing Medical Education Committee (CME) has curated research presentations given at the ARVO 2021 Annual Meeting into five accredited online courses. Each course offers between two and three CME credits and will be accessible via ARVOLearn until Dec. 31.

Click the links below to view the list of presentations offered in each course:

If you did not attend ARVO 2021, you can still participate in the CME courses by purchasing the course bundle (courses are not sold separately).

This is a great opportunity to engage in online learning throughout the rest of the year. 

Course bundle fee:
  • $29 (Members-in-Training; Members)
  • $49 (Nonmembers)
  • Complimentary (ARVO 2021 registrants)
Organizers
Continuing Medical Education Committee (CME)

 Physician accreditation statement
The Association for Research in Vision and Ophthalmology (ARVO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Artificial intelligence: Detecting and classifying ophthalmic conditions

Description
This activity highlights new AI models and methods being explored by researchers and clinician-scientists to describe the structural signature of the glaucomatous optic nerve head, to detect and classify glaucoma progression, retinopathy of prematurity, and keratoconus, to quantify fluid volumes, automate the segmentation of geographic atrophy and develop an ocular theranostic platform for retinal diseases.

Estimated duration: 2 hours, 30 minutes

Physician credit designation: The Association for Research in Vision and Ophthalmology (ARVO) designates this enduring material activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target audience: The educational design of this activity addresses the needs of clinicians involved in the treatment of patients with eye and vision diseases and disorders.

Learning objectives: After attending this course, participants will be able to:
  • Discuss the results of artificial intelligence investigations and research relevant to my practice.
  • Explain which AI techniques would be most appropriate for my practice.
  • Outline new models and methods being used by researchers and clinicians in artificial intelligence.
  • Cite 2-3 ways in which the research data and methods presented may influence my practice.

Clinical trials for emerging treatments in eye diseases 

Description
This activity highlights research regarding implementation of strategies, techniques, and practices for applying this up-to-date information to clinical practice is provided to enhance learner competence.

Estimated duration: 2 hours
 
Physician credit designation: The Association for Research in Vision and Ophthalmology (ARVO) designates this enduring material activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target audience: The educational design of this activity addresses the needs of clinicians involved in the treatment of patients with eye and vision diseases and disorders.

Learning objectives: After attending this course, participants will be able to:
  • Discuss the results of clinical trials for new and emerging treatments in eye diseases and research relevant to my practice.
  • Outline new models and methods being used by researchers and clinicians in clinical trials for new and emerging treatments in eye diseases.
  • Cite 2-3 ways in which the research data and methods presented may influence my practice.

 

New findings in clinical/epidemiologic research 

Description
This activity highlights approaches regarding implementation of strategies, techniques, and practices for applying the up-to-date research findings and new advances to clinical practice are presented to enhance learner competence.

Estimated duration: 2 hours, 30 minutes

Physician credit designation: The Association for Research in Vision and Ophthalmology (ARVO) designates this enduring material activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target audience: The educational design of this activity addresses the needs of clinicians involved in the treatment of patients with eye and vision diseases and disorders.

Learning objectives: After attending this course, participants will be able to:
  • Discuss the most recent discoveries and advances in epidemiologic and clinical research in ocular diseases relevant to risk factors, diagnosis, and treatments.
  • Outline new models and methods being used by researchers and clinicians in epidemiologic and clinical research of ocular diseases that may improve the standard of patient care.
  • Cite 2-3 strategies and/or new diagnostic techniques that may influence my practice.

 

New discoveries in ocular genomics and epigenomics

Description
This activity highlights research regarding implementation of strategies, techniques, and practices for applying this up-to-date information to clinical practice is provided to enhance learner competence.

Estimated duration: 2 hours
 
Physician credit designation: The Association for Research in Vision and Ophthalmology (ARVO) designates this enduring material activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target audience: The educational design of this activity addresses the needs of clinicians involved in the treatment of patients with eye and vision diseases and disorders.

Learning objectives: After attending this course, participants will be able to:
  • Discuss the results of genomics and epigenomics investigations and research relevant to my practice.
  • Outline new models and methods being used by researchers and clinicians in genomics and epigenomics.
  • Cite 2-3 ways in which the research data and methods presented may influence my practice.

 

Advances in ocular imaging

Description
This activity highlights new models and methods being used by researchers and clinicians in ocular imaging across handheld OCT and pediatric patients, virtual networks, a multitask deep learning system, ultra-wide field imaging and deep archetypal analysis.

Estimated duration: 2 hours, 30 minutes
 
Physician credit designation: The Association for Research in Vision and Ophthalmology (ARVO) designates this enduring material activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Target audience: The educational design of this activity addresses the needs of clinicians involved in the treatment of patients with eye and vision diseases and disorders.

Learning objectives: After attending this course, participants will be able to:
  • Discuss the results of ocular imaging investigations and research relevant to my practice.
  • Outline new models and methods being used by researchers and clinicians in ocular imaging.
  • Cite 2-3 ways in which the research data and methods presented may influence my practice.